Company news
Nuvo Pharmaceuticals Inc news in 2015
Nuvo Pharmaceuticals Inc's news releases, calls and decks from 2015, newest first.
Nuvo Research® Reacquires Pliaglis North American Development and Marketing Rights
December 22, 2015
Nuvo Research® Reports Topline Results of Phase 2 Trial of WF10(TM) for the Treatment of Allergic Rhinitis
December 21, 2015
Nuvo Research® Announces Special Shareholder Meeting to Vote on Reorganization of Nuvo into Two Publicly Traded Companies
December 15, 2015
Nuvo Research® Provides Update on Pennsaid® 2% Phase 3 Clinical Trial
December 3, 2015
Nuvo Research® Announces Acceleration of Expiry Date of Outstanding Warrants
November 30, 2015
Nuvo Research® Announces TSX Conditional Approval to List Crescita Therapeutics Inc.
November 23, 2015
Nuvo Research® Announces 2015 Third Quarter Results
November 10, 2015
Nuvo Research Announces Successful Pennsaid®2% Phase 3 Trial for Russia
November 5, 2015
Nuvo Research® Announces Appointment to its Board of Directors
November 3, 2015
Nuvo Research® Announces Intention to Split Into Two Publicly Traded Companies
September 15, 2015
Nuvo Research® Announces U.S. Patent for Topical Foamed Formulations that Include DMSO
August 20, 2015
Nuvo Research® Announces Grant of United States Patent for Topical Onychomycosis Formulation
August 11, 2015
Nuvo Research® Announces 2015 Second Quarter Results
August 5, 2015
Nuvo Research® Provides Update on International Licensing of Pennsaid® 2%
June 24, 2015
Nuvo Research® Receives Health Canada Approval to Conduct New WF10(TM) Phase 2 Trial
June 8, 2015
Nuvo Research announces director election results of its Annual General Meeting
May 13, 2015
Nuvo Research® Announces 2015 First Quarter Results
May 12, 2015
Nuvo Research® Announces New WF10(TM) Phase 2 Trial
April 22, 2015
Nuvo Research® Updates Company Strategy
April 16, 2015
Nuvo Research® Provides Business Update
March 5, 2015
Nuvo Research® Announces 2014 Fourth Quarter & Year-End Results
February 19, 2015
Nuvo Research® Reports Topline Results of Phase 2 Study of WF10(TM) for the Treatment of Allergic Rhinitis
January 30, 2015